The man behind the president’s tumultuous tariff policies has sought for decades to set off the ultimate trade war with China ...

Goldman Sachs Asset Management (GSAM), the alternative investment division of Goldman Sachs Group Inc., has entered into an agreement to acquire a controlling stake in Dutch generic drug manufacturer ...